{"transactions":[{"id":4116828,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":170710,"kind":"person","name":"Bass Gregory Brooks","position":1,"cik":"0001696824","reported_name":"Bass Gregory Brooks","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Unit","published_at":"2018-01-02T23:16:17.000Z","date":"2017-12-29","kind":"exercise","acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to vesting whereby 1/4 of the shares subject to the award will vest on December 29, 2017 and the remaining 3/4 of the shares subject to the award will vest on the receipt by the Company of FDA approval of LPCN 1021."}],"balance_after":28125,"derivative":{"exercise_price":0,"exercise_date":"2017-12-29","expiration_date":"2027-01-25","underlying":"Common stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001638599-18-000030","document":"doc4_5170.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000030/doc4_5170.xml","form_type":"4"}},{"id":4116827,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":170710,"kind":"person","name":"Bass Gregory Brooks","position":1,"cik":"0001696824","reported_name":"Bass Gregory Brooks","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common stock","published_at":"2018-01-02T23:16:17.000Z","date":"2017-12-29","kind":"sale","acquired":false,"shares":3750,"price":3.4729,"value":13023.375,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average price of shares sold at a price that ranged from $3.43-$3.54."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001638599-18-000030","document":"doc4_5170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000030/doc4_5170.xml","form_type":"4"}},{"id":4116826,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":170710,"kind":"person","name":"Bass Gregory Brooks","position":1,"cik":"0001696824","reported_name":"Bass Gregory Brooks","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2018-01-02T23:16:17.000Z","date":"2017-12-29","kind":"exercise","acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of Lipocine Inc. common stock (\"LPCN Common Stock\") acquired upon the vesting of restricted stock units (see footnote 4)."}],"balance_after":9375,"source":{"system":"sec-edgar","filing":"0001638599-18-000030","document":"doc4_5170.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859918000030/doc4_5170.xml","form_type":"4"}},{"id":4140151,"issuer":{"id":7696,"kind":"organization","name":"Lipocine Inc."},"owners":[{"id":170710,"kind":"person","name":"Bass Gregory Brooks","position":1,"cik":"0001696824","reported_name":"Bass Gregory Brooks","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Commercial Offic"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-12-06T23:51:00.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":75000,"price":3.52,"value":264000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 6, 2018, while the remaining 2/3 of the shares subject to the award have vesting monthly on a prorata basis over the following two years."}],"balance_after":75000,"derivative":{"exercise_price":3.52,"exercise_date":"2018-12-06","expiration_date":"2027-12-06","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001638599-17-001223","document":"doc4_5124.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1535955/000163859917001223/doc4_5124.xml","form_type":"4"}}]}